MedTrace Logo

Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter

NCT00318565 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 291

Last updated 2012-03-05

Study results available
· View outcomes & findings →

Summary

The primary objective is to provide additional corroborative safety and efficacy data for the Navistar Thermocool catheter for the treatment of subjects with typical atrial flutter (AFL).

Conditions

  • Atrial Flutter

Interventions

DEVICE

RF energy delivery for treatment of Typical Atrial flutter

Navistar ThermoCool catheter

Sponsors & Collaborators

  • Biosense Webster, Inc.

    lead INDUSTRY

Principal Investigators

  • Warren Jackman, M.D. · University of Oklahoma

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2007-09-30
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00318565 on ClinicalTrials.gov